Clinical Trial Update: New-diagnosed PCNSL Treated With Methotrexate (MTX) and Orelabrutinib-based Regimen

View source ↗

Summary

A completed clinical trial investigating the treatment of newly diagnosed primary central nervous system lymphoma with methotrexate plus an orelabrutinib-based …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Orelabrutinib (orelabrutinib)

Snippet

Sponsor: Huashan Hospital | Conditions: Primary Central Nervous System Lymphoma | Status: COMPLETED